Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.52
-0.2000-4.24%
Pre-market: 4.570.0500+1.11%06:29 EDT
Volume:977.97K
Turnover:4.46M
Market Cap:141.43M
PE:-1.09
High:4.77
Open:4.71
Low:4.50
Close:4.72
52wk High:50.40
52wk Low:4.50
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.51
T/O Rate:5.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.65
PE(LYR):-1.59

Loading ...

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 04

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 04

Rein Therapeutics to Present at Upcoming September Investor Conferences

GlobeNewswire
·
Sep 04

Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 03

Quince Therapeutics to Participate in September 2026 Investor Conferences

GlobeNewswire
·
Sep 03

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 03

Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 03

HC Wainwright Initiate Neurosense Therapeutics at Buy With $8 Price Target

MT Newswires Live
·
Sep 03

NeuroSense Therapeutics Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 03

TScan Therapeutics Cut to Hold from Buy by Needham

Dow Jones
·
Sep 03

Onconic Therapeutics Independent Director Resigns After Public Appointment

TIPRANKS
·
Sep 03

Cutia Therapeutics' Marketing Application for Botox Product Accepted in China

MT Newswires Live
·
Sep 03

IMPACT Therapeutics CEO Boosts Stake in Hong Kong–Listed Biopharma Group

TIPRANKS
·
Sep 03

Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference

TIPRANKS
·
Sep 03

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 03

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 03

Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 03

Needham Downgrades TScan Therapeutics to Hold From Buy

MT Newswires Live
·
Sep 03

TScan Therapeutics downgraded to Hold from Buy at Needham

TIPRANKS
·
Sep 03

Halozyme Therapeutics Price Target Maintained with a $115.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 03